Cargando…
Cytokine and Adipokine Levels in Patients with Premalignant Oral Lesions or in Patients with Oral Cancer Who Did or Did Not Receive 1α,25-Dihydroxyvitamin D(3) Treatment upon Cancer Diagnosis
Differences in levels of inflammation-modulating cytokines and adipokines in patients with premalignant oral lesions versus in patients that develop squamous cell carcinoma of the head and neck (HNSCC) were assessed. Also assessed was the impact of treating HNSCC patients with the immune regulatory...
Autores principales: | Young, M. Rita I., Levingston, Corinne, Johnson, Sara D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586760/ https://www.ncbi.nlm.nih.gov/pubmed/26120967 http://dx.doi.org/10.3390/cancers7030827 |
Ejemplares similares
-
Local Immune Responsiveness of Mice Bearing Premalignant Oral Lesions to PD-1 Antibody Treatment
por: Levingston, Corinne A., et al.
Publicado: (2017) -
Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD‐1 antibodies
por: Levingston, Corinne A., et al.
Publicado: (2017) -
Indomethacin Treatment of Mice with Premalignant Oral Lesions Sustains Cytokine Production and Slows Progression to Cancer
por: Johnson, Sara D., et al.
Publicado: (2016) -
Oral Premalignancy
por: Hume, W.
Publicado: (1981) -
Prospective Comparison of Hepatocellular Carcinoma Behavior and Survival of Patients who Did or Did not Receive HCV Direct-Acting Antivirals
por: El-Kassas, Mohamed, et al.
Publicado: (2023)